What happened: Two years after trading starter Yusei Kikuchi to Houston, the ripple effects of the transaction continue to shape the Toronto Blue Jays organization. While initially praised as a significant prospect haul, the primary pieces acquired have seen varied paths, with two already departed and the lone remaining pitcher working back from injury.
Why it matters: The outcome highlights the volatility of deadline deals for a club that is currently 33-36 and seeking consistency in the AL East. With Joey Loperfido back in Houston and Will Wagner now in San Diego, Toronto’s return hinges on the recovery of Jake Bloss following his 2025 UCL surgery. The Toronto Blue Jays are navigating a challenging season while waiting for their 2024 investments to mature.
By the numbers: Joey Loperfido: .253 AVG, 8 HR (2026); Will Wagner: .255 AVG in 110 AB; Jake Bloss: Triple-A Buffalo (6.91 ERA post-trade, May 2025 UCL surgery).
What to watch: Toronto will monitor Bloss’s progress in Triple-A as he attempts to rejoin the major league rotation later this season.